Differences in the Comparative Stability of Ebola Virus Makona-C05 and Yambuku-Mayinga in Blood

• Michael Schuit,

  Affiliation National Biodefense Analysis and Countermeasures Center, Frederick, MD, United States of America

  ⨯
• David M. Miller,

  Affiliation National Biodefense Analysis and Countermeasures Center, Frederick, MD, United States of America

  ⨯
• Mary S. Reddick-Elick,

  Affiliation National Biodefense Analysis and Countermeasures Center, Frederick, MD, United States of America

  ⨯
• Carly B. Wlazlowski,

  Affiliation National Biodefense Analysis and Countermeasures Center, Frederick, MD, United States of America

  ⨯
• Claire Marie Filone,

  Affiliation National Biodefense Analysis and Countermeasures Center, Frederick, MD, United States of America

  ⨯
• Artemas Herzog,

  Affiliation Censeo Consulting Group, Washington, DC, United States of America

  ⨯
• Leremy A. Colf,

  Affiliation Department of Homeland Security (DHS) Science and Technology Directorate, Washington, DC, United States of America

  ⨯
• Victoria Wahl-Jensen,

  Affiliation National Biodefense Analysis and Countermeasures Center, Frederick, MD, United States of America

  ⨯
• Michael Hevey,

  Affiliation National Biodefense Analysis and Countermeasures Center, Frederick, MD, United States of America

  ⨯
• James W. Noah

  * E-mail: james.noah@nbacc.dhs.gov

  Affiliation National Biodefense Analysis and Countermeasures Center, Frederick, MD, United States of America

  ⨯